Magnitude International Ltd

Introduction

This page provides a comprehensive analysis of the known insider trading history of Gary C Evans. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

See Highest Ranking Insiders
Companies with Reported Insider Positions

The SEC filings indicate Gary C Evans has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:UAMY / United States Antimony Corporation Chairman & CEO, Director 1,528,818
US:NVAX / Novavax, Inc. Director 0
US:MAGH / Magnitude International Ltd Chairman and CEO, Director 3,656,786
Chairman and Interim CEO, Director, 10% Owner 3,502,712
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Gary C Evans. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases MAGH / Magnitude International Ltd - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in MAGH / Magnitude International Ltd. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
2013-12-11 MHR EVANS GARY C 25,000 6.0900 25,000 6.0900 152,250 71
2013-12-11 MHR EVANS GARY C 5,000 6.0600 5,000 6.0600 30,300

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MAGH / Magnitude International Ltd Insider Trades
Insider Sales MAGH / Magnitude International Ltd - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in MAGH / Magnitude International Ltd. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
2012-06-29 MHR EVANS GARY C 100,000 4.1000 100,000 4.1000 410,000 298
2012-06-27 MHR EVANS GARY C 100,000 4.0100 100,000 4.0100 401,000
2012-06-15 MHR EVANS GARY C 75,000 4.1300 75,000 4.1300 309,750
2012-06-11 MHR EVANS GARY C 50,000 3.9645 50,000 3.9645 198,225

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MAGH / Magnitude International Ltd Insider Trades
Insider Purchases NVAX / Novavax, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in MAGH / Magnitude International Ltd. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
2007-08-22 NVAX EVANS GARY C 20,000 3.0990 1,000 61.9800 61,980 70 84 22,020 35.53
2006-08-22 NVAX EVANS GARY C 50,000 3.5500 2,500 71.0000 177,500
2006-08-22 NVAX EVANS GARY C 4,000 3.5500 200 71.0000 14,200
2006-08-22 NVAX EVANS GARY C 3,600 3.4900 180 69.8000 12,564
2006-08-22 NVAX EVANS GARY C 400 3.5100 20 70.2000 1,404
2006-01-25 NVAX EVANS GARY C 50,000 4.0000 2,500 80.0000 200,000
2005-12-08 NVAX EVANS GARY C 50,000 3.4980 2,500 69.9600 174,900
2005-12-07 NVAX EVANS GARY C 50,000 3.6000 2,500 72.0000 180,000
2005-11-14 NVAX EVANS GARY C 40,000 2.8940 2,000 57.8800 115,760
2005-11-11 NVAX EVANS GARY C 5,000 3.1200 250 62.4000 15,600
2005-09-12 NVAX EVANS GARY C 26,000 1.5000 1,300 30.0000 39,000
2005-09-12 NVAX EVANS GARY C 15,000 1.5500 750 31.0000 23,250
2005-09-06 NVAX EVANS GARY C 44,000 1.2900 2,200 25.8000 56,760
2005-08-24 NVAX EVANS GARY C 100,000 0.9415 5,000 18.8300 94,150
2005-08-23 NVAX EVANS GARY C 50,000 0.9750 2,500 19.5000 48,750
2005-08-22 NVAX EVANS GARY C 50,000 0.9748 2,500 19.4960 48,740
2004-09-27 NVAX EVANS GARY C 10,000 3.1400 500 62.8000 31,400
2004-09-13 NVAX EVANS GARY C 8,697 3.5400 435 70.8000 30,787
2004-09-10 NVAX EVANS GARY C 1,603 3.2400 80 64.8000 5,194

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

NVAX / Novavax, Inc. Insider Trades
Insider Sales NVAX / Novavax, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in MAGH / Magnitude International Ltd. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
2021-06-01 NVAX EVANS GARY C 625 146.5000 625 146.5000 91,562 344 42.9200 -64,737 -70.70
2021-03-15 NVAX EVANS GARY C 9,732 210.0000 9,732 210.0000 2,043,720
2021-03-15 NVAX EVANS GARY C 14,768 212.0000 14,768 212.0000 3,130,816
2020-08-18 NVAX EVANS GARY C 10,500 150.4400 10,500 150.4400 1,579,620
2016-06-06 NVAX EVANS GARY C 18,998 6.5000 950 130.0000 123,487
2016-05-24 NVAX EVANS GARY C 16,134 5.4230 807 108.4600 87,495
2016-05-23 NVAX EVANS GARY C 33,866 5.4000 1,693 108.0000 182,876
2015-08-24 NVAX EVANS GARY C 20,000 11.2404 1,000 224.8080 224,808
2015-08-13 NVAX EVANS GARY C 6,002 13.5618 300 271.2360 81,398
2014-12-16 NVAX EVANS GARY C 46,701 5.7154 2,335 114.3080 266,915
2014-12-12 NVAX EVANS GARY C 30,000 5.7654 1,500 115.3080 172,962
2013-04-24 NVAX EVANS GARY C 39,000 2.4600 1,950 49.2000 95,940
2013-04-24 NVAX EVANS GARY C 40,000 2.4400 2,000 48.8000 97,600

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

NVAX / Novavax, Inc. Insider Trades
Insider Purchases UAMY / United States Antimony Corporation - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in MAGH / Magnitude International Ltd. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
2024-12-10 UAMY EVANS GARY C 200,000 1.4470 200,000 1.4470 289,400 259 4.9400 698,600 241.40
2023-01-19 UAMY EVANS GARY C 21,068 0.4500 21,068 0.4500 9,481
2023-01-18 UAMY EVANS GARY C 300 0.4500 300 0.4500 135
2023-01-13 UAMY EVANS GARY C 31,369 0.4500 31,369 0.4500 14,116
2023-01-12 UAMY EVANS GARY C 20,944 0.4500 20,944 0.4500 9,425
2023-01-11 UAMY EVANS GARY C 5,137 0.4500 5,137 0.4500 2,312
2022-12-16 UAMY EVANS GARY C 147,994 0.4500 147,994 0.4500 66,597
2022-12-15 UAMY EVANS GARY C 119,201 0.4500 119,201 0.4500 53,640
2022-12-14 UAMY EVANS GARY C 68,990 0.4500 68,990 0.4500 31,046
2022-12-13 UAMY EVANS GARY C 238,212 0.4500 238,212 0.4500 107,195
2022-12-10 UAMY EVANS GARY C 13,999 0.4500 13,999 0.4500 6,300
2022-12-09 UAMY EVANS GARY C 65,902 0.4200 65,902 0.4200 27,679
2022-12-08 UAMY EVANS GARY C 51,653 0.4100 51,653 0.4100 21,178
2022-12-07 UAMY EVANS GARY C 251,281 0.4000 251,281 0.4000 100,512
2022-12-06 UAMY EVANS GARY C 40,000 0.3800 40,000 0.3800 15,200

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

UAMY / United States Antimony Corporation Insider Trades
Insider Sales UAMY / United States Antimony Corporation - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in MAGH / Magnitude International Ltd. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

UAMY / United States Antimony Corporation Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Gary C Evans as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change		 Share
Price		 Tran
Value		 Remaining
Value
2024-12-11 2024-12-10 4 UAMY UNITED STATES ANTIMONY CORP
Common Stock 		P - Purchase 200,000 1,528,818 15.05 1.45 289,400 2,212,200
2024-05-22 2024-03-01 4 UAMY UNITED STATES ANTIMONY CORP
Common Stock 		A - Award 250,000 1,326,050 23.23
2023-01-20 2023-01-19 4 UAMY UNITED STATES ANTIMONY CORP
UAMY-Common Stock 		P - Purchase 21,068 956,849 2.25 0.45 9,481 430,582
2023-01-20 2023-01-18 4 UAMY UNITED STATES ANTIMONY CORP
UAMY-Common Stock 		P - Purchase 300 935,781 0.03 0.45 135 421,101
2023-01-17 2023-01-13 4 UAMY UNITED STATES ANTIMONY CORP
UAMY-Common Stock 		P - Purchase 31,369 935,481 3.47 0.45 14,116 420,966
2023-01-17 2023-01-12 4 UAMY UNITED STATES ANTIMONY CORP
UAMY-Common Stock 		P - Purchase 20,944 904,112 2.37 0.45 9,425 406,850
2023-01-17 2023-01-11 4 UAMY UNITED STATES ANTIMONY CORP
UAMY-Common Stock 		P - Purchase 5,137 883,168 0.59 0.45 2,312 397,426
2022-12-21 2022-12-16 4 UAMY UNITED STATES ANTIMONY CORP
UAMY-Common Stock 		P - Purchase 147,994 864,032 20.67 0.45 66,597 388,814
2022-12-21 2022-12-10 4 UAMY UNITED STATES ANTIMONY CORP
UAMY-Common Stock 		P - Purchase 13,999 878,031 1.62 0.45 6,300 395,114
2022-12-16 2022-12-15 4 UAMY UNITED STATES ANTIMONY CORP
Common Stock 		P - Purchase 119,201 835,239 16.65 0.45 53,640 375,858
2022-12-15 2022-12-14 4 UAMY UNITED STATES ANTIMONY CORP
UAMY - Common Stock 		P - Purchase 68,990 716,038 10.66 0.45 31,046 322,217
2022-12-15 2022-12-13 4 UAMY UNITED STATES ANTIMONY CORP
UAMY - Common Stock 		P - Purchase 238,212 647,048 58.27 0.45 107,195 291,172
2022-12-12 2022-12-09 4 UAMY UNITED STATES ANTIMONY CORP
UAMY - Common Stock 		P - Purchase 65,902 408,836 19.22 0.42 27,679 171,711
2022-12-12 2022-12-08 4 UAMY UNITED STATES ANTIMONY CORP
UAMY - Common Stock 		P - Purchase 51,653 342,934 17.73 0.41 21,178 140,603
2022-12-12 2022-12-07 4 UAMY UNITED STATES ANTIMONY CORP
UAMY - Common Stock 		P - Purchase 251,281 291,281 628.20 0.40 100,512 116,512
2022-12-09 2022-12-06 4 UAMY UNITED STATES ANTIMONY CORP
UAMY-Common Stock 		P - Purchase 40,000 40,000 0.38 15,200 15,200
2021-06-22 2021-06-17 4 NVAX NOVAVAX INC
Restricted Stock Units 		M - Exercise -3,450 0 -100.00
2021-06-22 2021-06-17 4 NVAX NOVAVAX INC
Common Stock 		M - Exercise 3,450 19,549 21.43
2021-06-03 2021-06-01 4 NVAX NOVAVAX INC
Common Stock 		S - Sale -625 0 -100.00 146.50 -91,562
2021-03-17 2021-03-15 4 NVAX NOVAVAX INC
Stock Option (Right to Buy) 		M - Exercise -18,000 0 -100.00
2021-03-17 2021-03-15 4 NVAX NOVAVAX INC
Stock Option (Right to Buy) 		M - Exercise -4,500 0 -100.00
2021-03-17 2021-03-15 4 NVAX NOVAVAX INC
Stock Option (Right to Buy) 		M - Exercise -2,000 0 -100.00
2021-03-17 2021-03-15 4 NVAX NOVAVAX INC
Common Stock 		S - Sale -14,768 16,099 -47.84 212.00 -3,130,816 3,412,988
2021-03-17 2021-03-15 4 NVAX NOVAVAX INC
Common Stock 		S - Sale -9,732 30,867 -23.97 210.00 -2,043,720 6,482,070
2021-03-17 2021-03-15 4 NVAX NOVAVAX INC
Common Stock 		M - Exercise 18,000 40,599 79.65 3.98 71,730 161,787
2021-03-17 2021-03-15 4 NVAX NOVAVAX INC
Common Stock 		M - Exercise 4,500 22,599 24.86 46.00 207,000 1,039,554
2021-03-17 2021-03-15 4 NVAX NOVAVAX INC
Common Stock 		M - Exercise 2,000 18,099 12.42 99.80 199,600 1,806,280
2020-08-20 2020-08-18 4 NVAX NOVAVAX INC
Stock Option (Right to Buy) 		M - Exercise -4,000 0 -100.00
2020-08-20 2020-08-18 4 NVAX NOVAVAX INC
Stock Option (Right to Buy) 		M - Exercise -4,000 0 -100.00
2020-08-20 2020-08-18 4 NVAX NOVAVAX INC
Stock Option (Right to Buy) 		M - Exercise -1,500 0 -100.00
2020-08-20 2020-08-18 4 NVAX NOVAVAX INC
Stock Option (Right to Buy) 		M - Exercise -1,000 0 -100.00
2020-08-20 2020-08-18 4 NVAX NOVAVAX INC
Common Stock 		S - Sale -10,500 321,979 -3.16 150.44 -1,579,620 48,438,521
2020-08-20 2020-08-18 4 NVAX NOVAVAX INC
Common Stock 		M - Exercise 4,000 332,479 1.22 27.60 110,400 9,176,420
2020-08-20 2020-08-18 4 NVAX NOVAVAX INC
Common Stock 		M - Exercise 4,000 332,479 1.22 27.60 110,400 9,176,420
2020-08-20 2020-08-18 4 NVAX NOVAVAX INC
Common Stock 		M - Exercise 1,500 324,479 0.46 36.60 54,900 11,875,931
2020-08-20 2020-08-18 4 NVAX NOVAVAX INC
Common Stock 		M - Exercise 1,000 322,979 0.31 50.00 50,000 16,148,950
2020-06-26 2020-06-25 4 NVAX NOVAVAX INC
Restricted Stock Units 		A - Award 3,450 3,450
2020-06-26 2020-06-25 4 NVAX NOVAVAX INC
Stock Option (Right to buy) 		A - Award 6,900 6,900
2019-12-16 2019-12-12 4 NVAX NOVAVAX INC
Stock Option (Right to buy) 		A - Award 18,000 18,000
2018-12-14 2018-12-13 4 NVAX NOVAVAX INC
Stock Option (Right to buy) 		A - Award 90,000 90,000
2017-12-19 2017-12-15 4 NVAX NOVAVAX INC
Stock Option (Right to buy) 		A - Award 80,000 80,000
2017-03-20 2017-03-16 4 NVAX NOVAVAX INC
Stock Option (Right to buy) 		A - Award 80,000 80,000
2016-06-07 2016-06-06 4 NVAX NOVAVAX INC
Common Stock 		S - Sale -18,998 321,979 -5.57 6.50 -123,487 2,092,864
2016-05-25 2016-05-24 4 NVAX NOVAVAX INC
Common Stock 		S - Sale -16,134 340,977 -4.52 5.42 -87,495 1,849,118
2016-05-25 2016-05-23 4 NVAX NOVAVAX INC
Common Stock 		S - Sale -33,866 357,111 -8.66 5.40 -182,876 1,928,399
2016-03-17 2016-03-15 4 NVAX NOVAVAX INC
Stock Option (Right to buy) 		A - Award 40,000 40,000
2016-02-18 2016-02-17 4 NVAX NOVAVAX INC
Stock Option (Right to buy) 		M - Exercise -50,000 0 -100.00
2016-02-18 2016-02-17 4 NVAX NOVAVAX INC
Common Stock 		M - Exercise 50,000 390,977 14.66 4.60 230,000 1,798,494
2016-01-12 2016-01-08 4 MHRCQ MAGNUM HUNTER RESOURCES CORP
Common Stock, $0.01 par value 		J - Other -99,000 3,656,786 -2.64
2015-12-14 2015-12-10 4 MHRC MAGNUM HUNTER RESOURCES CORP
Common Stock, $0.01 par value 		F - Taxes -45,579 3,755,786 -1.20
2015-08-26 2015-08-24 4 NVAX NOVAVAX INC
Common Stock 		S - Sale -20,000 340,977 -5.54 11.24 -224,808 3,832,718
2015-08-17 2015-08-13 4 NVAX NOVAVAX INC
Stock Option (Right to buy) 		M - Exercise -30,000 0 -100.00
2015-08-17 2015-08-13 4 NVAX NOVAVAX INC
Stock Option (Right to buy) 		M - Exercise -15,000 0 -100.00
2015-08-17 2015-08-13 4 NVAX NOVAVAX INC
Common Stock 		S - Sale -6,002 360,977 -1.64 13.56 -81,398 4,895,498
2015-08-17 2015-08-13 4 NVAX NOVAVAX INC
Common Stock 		M - Exercise 30,000 366,979 8.90 1.28 38,400 469,733
2015-08-17 2015-08-13 4 NVAX NOVAVAX INC
Common Stock 		M - Exercise 15,000 336,979 4.66 0.56 8,400 188,708
2015-04-01 2015-03-30 4 MHR MAGNUM HUNTER RESOURCES CORP
Common Stock, $0.01 par value 		A - Award 94,862 3,801,365 2.56
2015-03-09 2015-03-05 4 NVAX NOVAVAX INC
Stock Option (Right to buy) 		A - Award 40,000 40,000
2015-01-27 2015-01-23 4 grh GreenHunter Resources, Inc.
COMMON STOCK, PAR VALUE $.001 		P - Purchase 166,666 3,502,712 5.00 0.60 100,000 2,101,627
2014-12-23 2014-12-19 4 GRH GreenHunter Resources, Inc.
COMMON STOCK, PAR VALUE $.001 		A - Award 1,500,000 3,336,046 81.70 0.56 840,000 1,868,186
2014-12-23 2014-12-19 4 MHR MAGNUM HUNTER RESOURCES CORP
Common Stock, $0.01 par value 		F - Taxes -45,593 3,706,503 -1.22 3.39 -154,560 12,565,045
2014-12-18 2014-12-16 4 NVAX NOVAVAX INC
Stock Option (Right to buy) 		M - Exercise -200,000 0 -100.00
2014-12-18 2014-12-16 4 NVAX NOVAVAX INC
Stock Option (Right to buy) 		M - Exercise -35,000 0 -100.00
2014-12-18 2014-12-16 4 NVAX NOVAVAX INC
Stock Option (Right to buy) 		M - Exercise -15,000 0 -100.00
2014-12-18 2014-12-16 4 NVAX NOVAVAX INC
Common Stock 		S - Sale -46,701 313,979 -12.95 5.72 -266,915 1,794,516
2014-12-18 2014-12-16 4 NVAX NOVAVAX INC
Common Stock 		M - Exercise 235,000 360,680 186.98 1.03 242,050 371,500
2014-12-18 2014-12-16 4 NVAX NOVAVAX INC
Common Stock 		M - Exercise 15,000 125,680 13.55 1.48 22,200 186,006
2014-12-16 2014-12-12 4 NVAX NOVAVAX INC
Common Stock 		S - Sale -30,000 110,680 -21.32 5.77 -172,962 638,114
2014-11-10 2014-11-06 4 MHR MAGNUM HUNTER RESOURCES CORP
Common Stock, $0.01 par value 		A - Award 500,000 3,752,096 15.37
2014-10-14 2014-10-10 4 MHR MAGNUM HUNTER RESOURCES CORP
Common Stock, $0.01 par value 		J - Other -2,000,000 3,252,096 -38.08
2014-05-19 2014-05-15 4 GRH GreenHunter Resources, Inc.
COMMON STOCK, PAR VALUE $.001 		P - Purchase 2,000 22,000 10.00 0.99 1,980 21,780
2014-05-01 2014-04-29 4 GRH GreenHunter Resources, Inc.
COMMON STOCK, PAR VALUE $.001 		P - Purchase 1,200 15,000 8.70 0.99 1,188 14,850
2014-05-01 2014-04-29 4 GRH GreenHunter Resources, Inc.
COMMON STOCK, PAR VALUE $.001 		P - Purchase 8,800 13,800 176.00 0.98 8,624 13,524
2014-04-30 2014-04-28 4 GRH GreenHunter Resources, Inc.
COMMON STOCK, PAR VALUE $.001 		P - Purchase 5,000 5,000 0.98 4,900 4,900
2014-04-29 2014-04-25 4 GRH GreenHunter Resources, Inc.
COMMON STOCK,PAR VALUE $.001 		P - Purchase 3,900 15,800 32.77 1.00 3,900 15,800
2014-04-29 2014-04-25 4 GRH GreenHunter Resources, Inc.
COMMON STOCK, PAR VALUE $.001 		P - Purchase 100 11,900 0.85 0.99 99 11,781
2014-03-07 2014-03-06 4 NVAX NOVAVAX INC
Stock Option (Right to buy) 		A - Award 30,000 655,000 4.80
2014-01-13 2014-01-08 4 MHR MAGNUM HUNTER RESOURCES CORP
Common Stock, $0.01 par value 		A - Award 300,000 5,252,096 6.06
2013-12-12 2013-12-11 4 MHR MAGNUM HUNTER RESOURCES CORP
Common Stock, $0.01 par value 		P - Purchase 5,000 4,952,096 0.10 6.06 30,300 30,009,702
2013-12-12 2013-12-11 4 MHR MAGNUM HUNTER RESOURCES CORP
Common Stock, $0.01 par value 		P - Purchase 25,000 4,947,096 0.51 6.09 152,250 30,127,815
2013-12-12 2013-09-13 4 MHR MAGNUM HUNTER RESOURCES CORP
Common Stock, $0.01 par value 		X - Other 3,479 134,164 2.66
2013-04-26 2013-04-24 4 NVAX NOVAVAX INC
Common Stock 		S - Sale -40,000 702,558 -5.39 2.44 -97,600 1,714,242
2013-04-26 2013-04-24 4 NVAX NOVAVAX INC
Common Stock 		S - Sale -39,000 742,558 -4.99 2.46 -95,940 1,826,693
2013-03-06 2013-03-02 4 NVAX NOVAVAX INC
Options-right to buy 		A - Award 30,000 667,500 4.71 1.83 54,900 1,221,525
2013-01-24 2013-01-23 4 GRH GreenHunter Energy, Inc.
Common Stock, Par value $.001 		A - Award 214,359 1,836,046 13.22 1.90 407,282 3,488,487
2013-01-24 2013-01-23 4 GRH GreenHunter Energy, Inc.
Common Stock, Par value $.001 		A - Award 1,111,111 1,621,687 217.62 0.90 1,000,000 1,459,518
2013-01-22 2013-01-17 4 MHR MAGNUM HUNTER RESOURCES CORP
Employee Stock Option - Right to buy 		A - Award 750,000 750,000
2012-11-07 2012-11-05 4 MHR MAGNUM HUNTER RESOURCES CORP
Common Stock, $0.01 par value 		X - Other 8,670 4,922,096 0.18 2.50 21,675 12,305,240
2012-11-07 2012-10-29 4 MHR MAGNUM HUNTER RESOURCES CORP
Right to buy - Common Stock Warrants 		X - Other -8,670 0 -100.00
2012-11-07 2012-08-16 4 MHR MAGNUM HUNTER RESOURCES CORP
Common Stock, $0.01 par value 		X - Other 4,186 130,686 3.31
2012-06-29 2012-06-29 4 MHR MAGNUM HUNTER RESOURCES CORP
Common Stock, $0.01 par value 		S - Sale -100,000 4,913,426 -1.99 4.10 -410,000 20,145,047
2012-06-29 2012-06-27 4 MHR MAGNUM HUNTER RESOURCES CORP
Common Stock, $0.01 par value 		S - Sale -100,000 5,013,426 -1.96 4.01 -401,000 20,103,838
2012-06-19 2012-06-15 4 MHR MAGNUM HUNTER RESOURCES CORP
Common Stock, $0.01 par value 		S - Sale -75,000 5,113,426 -1.45 4.13 -309,750 21,118,449
2012-06-13 2012-06-11 4 MHR MAGNUM HUNTER RESOURCES CORP
Common Stock, $0.01 par value 		S - Sale -50,000 5,188,426 -0.95 3.96 -198,225 20,569,515
2012-04-17 2012-04-13 4 MHR MAGNUM HUNTER RESOURCES CORP
Employee Stock Option - Right to Buy 		A - Award 750,000 750,000
2012-03-08 2012-03-01 4 NVAX NOVAVAX INC
Options-right to buy 		A - Award 20,000 247,680 8.78 1.28 25,600 317,030
2012-01-05 2012-01-03 4 GRH GreenHunter Energy, Inc.
COMMON STOCK 		P - Purchase 5,000 10,800 86.21 0.87 4,350 9,396
2012-01-05 2012-01-03 4 GRH GreenHunter Energy, Inc.
COMMON STOCK 		P - Purchase 5,000 0 -100.00 0.87 4,333
2007-08-23 2007-08-22 4 NVAX NOVAVAX INC
Common Stock 		P - Purchase 20,000 833,300 2.46 3.10 61,980 2,582,397
2007-03-09 2007-03-07 4 NVAX NOVAVAX INC
Option - right to buy 		A - Award 100,000 100,000
2006-08-23 2006-08-22 4 NVAX NOVAVAX INC
Gary C. Evans Custodian for Casey Evans UTMA/TX 		P - Purchase 400 4,000 11.11 3.51 1,404 14,040
2006-08-23 2006-08-22 4 NVAX NOVAVAX INC
Gary C. Evans Custodian for Casey Evans UTMA/TX 		P - Purchase 3,600 3,600 3.49 12,564 12,564
2006-08-23 2006-08-22 4 NVAX NOVAVAX INC
Gary C. Evans Custodian for Dustin Evans UTMA/TX 		P - Purchase 4,000 4,000 3.55 14,200 14,200
2006-08-23 2006-08-22 4 NVAX NOVAVAX INC
Common Stock ($.01 par value) 		P - Purchase 50,000 813,300 6.55 3.55 177,500 2,887,215
2006-02-22 2006-02-17 4 NVAX NOVAVAX INC
Option 		A - Award 50,000 50,000 4.60 230,000 230,000
2006-01-26 2006-01-25 4 NVAX NOVAVAX INC
Common Stock ($.01 par value) 		P - Purchase 50,000 738,300 7.26 4.00 200,000 2,953,200
2005-12-08 2005-12-08 4 NVAX NOVAVAX INC
Common Stock ($.01 par value) 		P - Purchase 50,000 688,300 7.83 3.50 174,900 2,407,673
2005-12-08 2005-12-07 4 NVAX NOVAVAX INC
Common Stock ($.01 par value) 		P - Purchase 50,000 638,300 8.50 3.60 180,000 2,297,880
2005-11-15 2005-11-14 4 NVAX NOVAVAX INC
Common Stock ($.01 par value) 		P - Purchase 40,000 588,300 7.30 2.89 115,760 1,702,540
2005-11-15 2005-11-11 4 NVAX NOVAVAX INC
Common Stock ($.01 par value) 		P - Purchase 5,000 548,300 0.92 3.12 15,600 1,710,696
2005-09-13 2005-09-12 4 NVAX NOVAVAX INC
Common Stock ($.01 par value) 		P - Purchase 15,000 543,300 2.84 1.55 23,250 842,115
2005-09-13 2005-09-12 4 NVAX NOVAVAX INC
Common Stock ($.01 par value) 		P - Purchase 26,000 528,300 5.18 1.50 39,000 792,450
2005-09-09 2005-09-06 4/A NVAX NOVAVAX INC
Common Stock ($.01 par value) 		P - Purchase 44,000 502,300 9.60 1.29 56,760 647,967
2005-09-07 2005-09-06 4 NVAX NOVAVAX INC
Common Stock ($.01 par value) 		A - Award 44,000 502,300 9.60 1.29 56,760 647,967
2005-08-26 2005-08-24 4 NVAX NOVAVAX INC
Common Stock ($.01 par value) 		P - Purchase 100,000 458,300 27.91 0.94 94,150 431,489
2005-08-26 2005-08-23 4 NVAX NOVAVAX INC
Common Stock ($.01 par value) 		P - Purchase 50,000 358,300 16.22 0.98 48,750 349,342
2005-08-24 2005-08-22 4 NVAX NOVAVAX INC
Common Stock ($.01 par value) 		P - Purchase 50,000 308,300 19.36 0.97 48,740 300,531
2005-05-06 2005-05-04 4 NVAX NOVAVAX INC
Option (1) 		A - Award 15,000 108,300 16.08 1.48 22,200 160,284
2004-09-28 2004-09-27 4 NVAX NOVAVAX INC
Common Stock ($.01 par value) 		P - Purchase 10,000 108,300 10.17 3.14 31,400 340,062
2004-09-13 2004-09-13 4 NVAX NOVAVAX INC
Common Stock ($.01 par value) 		P - Purchase 8,697 98,300 9.71 3.54 30,787 347,982
2004-09-13 2004-09-10 4 NVAX NOVAVAX INC
Common Stock ($.01 par value) 		P - Purchase 1,603 89,603 1.82 3.24 5,194 290,314
2004-03-15 2004-03-09 4/A NVAX NOVAVAX INC
Right-To-Buy 		A - Award 20,000 102,500 24.24
2004-03-12 2004-03-09 4 NVAX NOVAVAX INC
Right to Buy 		A - Award 20,000 88,000 29.41
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)